TG c.4066del ;(p.C1356Vfs*2)

Variant ID: 8-133923683-GT-G

NM_003235.4(TG):c.4066del;(p.C1356Vfs*2)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study.

Bmc Cancer
Azribi, Fathi F; Abdou, Ehab E; Dawoud, Emad E; Ashour, Mohamed M; Kamal, Amgad A; Al Sayed, Mohamed M; Burney, Ikram I
Publication Date: 2021-12-20

Variant appearance in text: TG: 4065_4065del
PubMed Link: 34930165
Variant Present in the following documents:
  • 12885_2021_Article_9094.pdf
View BVdb publication page



Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study.

Bmc Cancer
Azribi, Fathi F; Abdou, Ehab E; Dawoud, Emad E; Ashour, Mohamed M; Kamal, Amgad A; Al Sayed, Mohamed M; Burney, Ikram I
Publication Date: 2021-12-20

Variant appearance in text: TG: 4065_4065del
PubMed Link: 34930165
Variant Present in the following documents:
  • 12885_2021_Article_9094.pdf
View BVdb publication page



Haplotype-resolved de novo assembly of the Vero cell line genome.

Npj Vaccines
Sène, Marie-Angélique MA; Kiesslich, Sascha S; Djambazian, Haig H; Ragoussis, Jiannis J; Xia, Yu Y; Kamen, Amine A AA
Publication Date: 2021-08-20

Variant appearance in text: TG: 4065delT
PubMed Link: 34417462
Variant Present in the following documents:
  • 41541_2021_358_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page